BioSpace News Archive

CCA Industries, Inc. announced that it will be posting a loss for the first quarter of fiscal 2018. The Company will be issuing its first quarter 2018 results on Monday, April 16, 2018.

The U.S. Food and Drug Administration today issued an order to restrict the sale and distribution of the Essure device to ensure that all women considering use of the permanent contraception device are provided with adequate risk information so that they can make informed decisions

DaVita Clinical Research (DCR), a specialty contract research organization and subsidiary of DaVita Inc. (NYSE: DVA) with services spanning the full spectrum of drug and device development, will present three research abstracts from company representatives and collaborators at the National Kidney Foundation’s 2018 Spring Clinical Meetings in Austin, Texas April 10-14.